Clinical Research Directory
Browse clinical research sites, groups, and studies.
LATe Cerclage in High-risk Pregnancies (LATCH)
Sponsor: Thomas Jefferson University
Summary
The goal of this clinical trial is to determine whether cervical cerclage reduces the risk of preterm birth in patients with a short transvaginal ultrasound (TVU) cervical length (CL) ≤25mm between 24 0/7-26 6/7 weeks.
Official title: Cervical Cerclage for Short Cervix at 24-26 Weeks of Gestation: a Randomized Controlled Trial
Key Details
Gender
FEMALE
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
329
Start Date
2023-11-10
Completion Date
2029-02
Last Updated
2026-05-29
Healthy Volunteers
Yes
Conditions
Interventions
Cervical cerclage
Transvaginal cervical cerclage placed between 24 0/7 - 26 6/7 weeks of gestation.
Vaginal Suppository Progesterone
Continuing or initiation of vaginal progesterone 200mg daily until 36 weeks of gestation.
Locations (2)
Atrium Health Carolinas Medical Center
Charlotte, North Carolina, United States
Thomas Jefferson University
Philadelphia, Pennsylvania, United States